HomeInsightsPE

Sms Pharmaceuticals Ltd PE Ratio

Sms Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

18.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

SMS Pharmaceuticals Ltd

NSE: SMSPHARMA

PE

34.4

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of SMS Pharmaceuticals Ltd is 34.4 as of 23 Nov 15:30 PM .
  • The P/E Ratio of SMS Pharmaceuticals Ltd changed from 13.2 on March 2019 to 30.2 on March 2024 . This represents a CAGR of 14.79% over 6 years.
  • The Latest Trading Price of SMS Pharmaceuticals Ltd is ₹ 241.25 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of SMS Pharmaceuticals Ltd

No data available

Company Fundamentals for SMS Pharmaceuticals Ltd

No data available

Image

SMS Pharmaceuticals Ltd

NSE: SMSPHARMA

Share Price

₹ 241.25

1.50 (0.63%)

stock direction

Last updated on: Nov 22, 2024

Market Price of SMS Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring SMS Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024241.25
21 Nov 2024239.75
19 Nov 2024250.95
18 Nov 2024255.1
14 Nov 2024262.35
13 Nov 2024260.4
12 Nov 2024271.65
11 Nov 2024280.65
08 Nov 2024295.65
07 Nov 2024305.7

SWOT Analysis Of SMS Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

2

T

BlinkX Score for SMS Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of SMS Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
SMS Pharmaceuticals Ltd342,042
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of SMS Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of SMS Pharmaceuticals Ltd

No data available

* All values are in %

About SMS Pharmaceuticals Ltd

  • SMS Pharmaceuticals Limited was incorporated in December, 1987.
  • The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
  • Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh.
  • Its business activity is a single primary business segment of 'Bulk Drugs'. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs.

SMS Pharmaceuticals Ltd News Hub

News

SMS Pharmaceuticals to conduct AGM

SMS Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be...

Read more

2024-08-08 00:00:00

News

Board of SMS Pharmaceuticals approves incorporation of subsidiary company

The Board of SMS Pharmaceuticals at its meeting held on 05 August 2024 has approved to inc...

Read more

2024-08-05 00:00:00

News

SMS Pharmaceuticals fixes record date for dividend

SMS Pharmaceuticals has fixed 23 September 2024 as record date for the purpose of determin...

Read more

2024-08-05 00:00:00

News

SMS Pharmaceuticals consolidated net profit rises 76.45% in the June 2024 quarter

Net profit of SMS Pharmaceuticals rose 76.45% to Rs 16.48 crore in the quarter ended June ...

Read more

2024-08-05 00:00:00

News

SMS Pharmaceuticals to convene board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 Nove...

Read more

2024-11-02 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of SMS Pharmaceuticals Ltd

What is the current PE Ratio of SMS Pharmaceuticals Ltd?

The Current PE Ratio of SMS Pharmaceuticals Ltd is 34.42 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of SMS Pharmaceuticals Ltd last year?

The PE Ratio of SMS Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 34.42, showing a year-on-year growth of -%.

What does the PE Ratio of SMS Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of SMS Pharmaceuticals Ltd is 34.42. This ratio indicates that investors are willing to pay 34.42 times the earnings per share for each share of SMS Pharmaceuticals Ltd.

What is the PE Ratio Growth of SMS Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of SMS Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -14.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*